Trial intelligence / Profile preview

Pharmatex cream contraceptive study in women over 40

2016-004188-38Phase 4Completed

Sponsor
InnoTech Precision Medicine
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of benzalkonium chloride in contraception, sponsored by InnoTech Precision Medicine. Primary endpoint: Contraceptive efficacy. Started Mar 2017; status: completed.

02

Drugs

benzalkonium chloride
03

Conditions

contraception

Beyond the preview

Go deeper on 2016-004188-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-004188-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call